Jeffery Keeslar Harris

COEP

CHIEF TECHNOLOGY OFFICER · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0002143921

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Aug 2026

HOLDINGS NOW

49,778

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Jeffery Keeslar Harris. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

Not enough transaction history to chart holdings.

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 0 buys / 0 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
COEP COEPTIS THERAPEUTICS HOLDINGS, INC.	ACQUIRE (DERIVATIVE)GRANT Stock grant	49,778	—	—	49,778	Aug 24, 2026	Aug 24, 2026 ↗	View →

Other insiders · COEP

Loading peer insiders…

About this filer

CIK 0002143921

ROLE

Chief Technology Officer

PRIMARY

COEP

COMPANIES

ACTIVE SINCE

Aug 2026

MARKETPEEL · /INSIDER/0002143921DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Jeffery Keeslar Harris

The morning brief, before the bell.